Journal of Pediatric Neurology 2020; 18(03): 157-160
DOI: 10.1055/s-0039-1687882
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Dexmedetomidine for Postoperative Sedation Following Stereotactic Lead Placement

Hope Xu*
1   Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Anthony H. Bui*
1   Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Maite La Vega-Talbott
2   Department of Neurology, Pediatric Neurology, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
,
Sheemon P. Zackai
3   Department of Pediatrics, Pediatric Critical Care Medicine, Kravis Children's Hospital at Mount Sinai, New York, New York, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

15. Januar 2019

18. März 2019

Publikationsdatum:
30. April 2019 (online)

Preview

Abstract

Dexmedetomidine has become an increasingly popular alternative to benzodiazepines and opioids as a safe agent for sedation and pain control, especially in pediatric populations. In this study, we present a case of postoperative use of dexmedetomidine in a pediatric patient, with a known history of behavioral difficulties, who underwent stereotactic lead placement for medically refractory epilepsy.

* Equal contribution